We serve Chemical Name:1-ethynyl-3-(trifluoromethoxy)benzene CAS:866683-57-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-ethynyl-3-(trifluoromethoxy)benzene
CAS.NO:866683-57-0
Synonyms:pc9568
Molecular Formula:C9H5F3O
Molecular Weight:186.13100
HS Code:2909309090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:166.3ºC at 760 mmHg
Density:1.27g/cm3
Index of Refraction:1.466
PSA:9.23000
Exact Mass:186.02900
LogP:2.56650
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like pc9568 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pc9568 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pc9568 Use and application,pc9568 technical grade,usp/ep/jp grade.
Related News: ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. 1-ethynyl-3-(trifluoromethoxy)benzene manufacturer “Whenever a company hires outside counsel to conduct an inquiry, it’s taken extremely seriously by the Justice Department,” said Paul Pelletier, a former long-time federal prosecutor who used to oversee criminal investigations of corporations. 1-ethynyl-3-(trifluoromethoxy)benzene supplier The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. 1-ethynyl-3-(trifluoromethoxy)benzene vendor ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. 1-ethynyl-3-(trifluoromethoxy)benzene factory Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.